Skip to main content

Advertisement

SpringerLink
Log in

The Prognostic Effect of Micrometastases in Previously Staged Lymph Node Negative (N0) Colorectal Carcinoma: A Meta-analysis

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The prognostic relevance of lymphatic micrometastases in colorectal carcinoma is unclear. To determine the prognostic significance of micrometastases in colorectal cancer, a meta-analysis was performed on all studies, which reported 3-year disease-free survival (DFS) and overall survival (OS).

Methods

Published studies selected for meta-analysis contained sufficient data from which to extrapolate estimates of 3-year DFS and/or OS. From 1991–2003, 25 studies re-examined N0 lymph nodes by serial sectioning and immunohistochemical (IHC) staining or reverse transcriptase-polymerase chain reaction (RT-PCR) assay. Eight studies (566 patients) with IHC detected micrometastases and three (173 patients) with RT-PCR micrometastases were used to determine DFS and OS. Weighted estimates of 3-year survival were combined across studies within each group, and the combined survival estimates were compared across groups using a binomial test.

Results

Micrometastases were identified in all IHC studies; upstaging, including N1, N1mi and N0(i+), was achieved in 32% (179/566 patients). All RT-PCR studies identified micrometastases; upstaging to N0(mol+) was achieved in 37% (64/173 patients). There was a statistically significant difference in 3-year OS between RT-PCR positive N0(mol+) patients (77.8%) and those for whom micrometastases were not detected (96.6%) (P<.001).

Conclusion

The prognostic value of micrometastases detected retrospectively by RT-PCR is significant in AJCC stage II colorectal patients. Studies utilizing RT-PCR performed a more complete nodal analysis when compared to studies using IHC techniques. RT-PCR may also be more specific for the detection of clinically relevant micrometastases compared to IHC detected cytokeratins. Prospective studies are needed to evaluate the potential benefit of systemic chemotherapy in patients with molecular metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Cancer Society. Cancer Facts and Figures 2006. Atlanta: American Cancer Society, 2006

    Google Scholar 

  2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10–30

    Google Scholar 

  3. Cohen AM, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Curr Prob Cancer 1998; 22:5–65

    Article  Google Scholar 

  4. Adell G, Boeryd B, Franlund B, et al. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: An immunohistochemical study. Eur J Surg 1996; 162:637–42

    CAS  PubMed  Google Scholar 

  5. Broll R, Schauer V, Schimmelpenning H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: An immunohistochemical study. Dis Colon Rectum 1997; 40:1465–71

    Article  CAS  PubMed  Google Scholar 

  6. Clarke G, Ryan E, O’Keane JC, Crowe J, MacMathuna P. The detection of cytokeratins in lymph nodes of Duke’s B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 2000; 12:549–52

    Article  CAS  PubMed  Google Scholar 

  7. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991; 34:917–20

    Article  CAS  PubMed  Google Scholar 

  8. Davidson B, Sams R, Styles J, et al. Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer 1990; 15;65:967–70

    Google Scholar 

  9. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: correlation with long-term survival. Cancer 1994; 73:563–9

    Article  CAS  PubMed  Google Scholar 

  10. Haboubi N, Clark P, Kaftan S, et al. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal cancer. J R Soc Med 1992; 85:386–8

    CAS  PubMed  Google Scholar 

  11. Hayashi N, Ito I, Yanagisawa A, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 1995; 345:1257–9

    Article  CAS  PubMed  Google Scholar 

  12. Isaka N, Nozue M, Doy M, et al. Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 1999; 5:2065–8

    CAS  PubMed  Google Scholar 

  13. Jeffers MD, O’Dowd GM, Mulcahy H, et al. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994; 172:183–7.

    Article  CAS  PubMed  Google Scholar 

  14. Makin C, Bobrow L, Nicholls J. Can immunohistology improve detection of lymph-node metastases in large-bowel cancer?. Dis Colon Rectum 1989; 32:99–102

    CAS  PubMed  Google Scholar 

  15. Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995; 55:3417–20

    CAS  PubMed  Google Scholar 

  16. Nakanishi Y, Atsushi O, Yamauchi Y, et al. Clinical implications of lymph node micrometastases in patients with colorectal cancers. Oncology 1999; 57:276–80

    Article  CAS  PubMed  Google Scholar 

  17. Nakamori S, Kameyama M, Furukawa H, et al. Genetic detection of colorectal cancer cells in circulation and lymph nodes. Dis Colon Rectum 1997; 40(suppl 10):S29–36

    Article  CAS  PubMed  Google Scholar 

  18. Nicholson AG, Marks CG, Cook MG. Effect on lymph node status of triple leveling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. Gut 1994; 35:1447–8

    CAS  PubMed  Google Scholar 

  19. Noura S, Yamamoto H, Miyake Y, et al. Immunohistochemical assessment of localization and frequency of micrometastasis in lymph nodes of colorectal cancer. Clin Cancer Res 2002; 8:759–67

    PubMed  Google Scholar 

  20. Oberg A, Stenling R, Tavelin B, et al. Are lymph node micrometastases of any clinical significance in Dukes stage A and B colorectal cancer? Dis Colon Rectum 1998; 41:1244–9

    Article  CAS  PubMed  Google Scholar 

  21. Palma RT, Waisberg J, Bromberg SH, et al. Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis 2003; 5:164–8

    Article  CAS  PubMed  Google Scholar 

  22. Sasaki M, Watanabe H, Jass JR, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in “node negative” colorectal cancer. J Gastroenterol 1997; 32:758–64

    CAS  PubMed  Google Scholar 

  23. Tschmelitsch J, Klimstra D, Cohen A. Lymph node micrometastases do not predict relapse in stage II colon cancer. Ann Surg Oncol 2000; 7:601–8

    CAS  PubMed  Google Scholar 

  24. Yasuda K, Adachi Y, Shiraishi N, et al. Pattern of lymph node micrometastases and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001; 8:300–4.

    Article  CAS  PubMed  Google Scholar 

  25. Yamamoto H, Miyake Y, Noura S, et al. [Clinical significance of micrometastasis to lymph nodes in gastrointestinal tract cancers]. Gan To Kagaku Ryoho 2001; 28:776–83

    CAS  PubMed  Google Scholar 

  26. Noura S, Hirofumi Y, Ohnishi T, et al. Comparative detection of lymph node micrometastasis of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistery. J Clin Oncol 2002; 20:4232–41

    Article  CAS  PubMed  Google Scholar 

  27. Liefers G, Cleton-James A, van de Velde C, et al. Micrometastasis and survival in stage II colorectal cancer. N Engl J Med 1998; 339:223–8

    Article  CAS  PubMed  Google Scholar 

  28. Rosenberg R, Hoos R, Mueller J, et al. Prognostic significance of cytokeratin-20 reverse-transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 2002; 20:1049–55

    Article  PubMed  Google Scholar 

  29. Benson AB, Schrag D, Somerfield M, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22:3408–19

    Article  PubMed  Google Scholar 

  30. Masuda N, Ohnishi T, Kawamoto S, et al. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res 1999; 27:4436–43

    Article  CAS  PubMed  Google Scholar 

  31. Masuda N, Tamaki Y, Sakita I, et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcriptase-polymerase chain reaction in breast cancer patients. Clin Cancer Res 2000; 6:4176–85

    CAS  PubMed  Google Scholar 

  32. Gerhard M, Juhl H, Kalthoff H, et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994; 12:725–9

    CAS  PubMed  Google Scholar 

  33. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156–9

    Article  CAS  PubMed  Google Scholar 

  34. Rosenberg R, Hoos A, Mueller J, et al. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detected by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer 2000; 83:1323–9

    Article  CAS  PubMed  Google Scholar 

  35. Funaki NO, Tanaka J, Ohshio G, et al. Cytokeratin-20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br J Cancer 1998; 77:1327–32

    CAS  PubMed  Google Scholar 

  36. Egger M, Smith GD, Sterne J. Uses and abuses of meta-analysis. Clin Med 2001; 1:478–84

    CAS  PubMed  Google Scholar 

  37. Law CHL, Wright FC, Rapanos T, et al. Impact of lymphnode retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol 2003; 84:120–6

    Article  PubMed  Google Scholar 

  38. Tempper JE, O’Connell MJ, Niedzwiecki D, et al. Impact of number of lymph nodes retriveved on outcome in patients with rectal cancer. J Clin Oncol 2001; 19:157–63

    Google Scholar 

  39. Burdy G, Panis Y, Alves A, et al. Identifying patients with T3–T4 node-negative colon cancer at high risk or recurrence. Dis Colon Rectum 2001; 44:1682–8

    Article  CAS  PubMed  Google Scholar 

  40. International Union Against Cancer (UICC). In: Sobin LH, Wittekind C, (eds). TMN classification of malignant tumors, 6th ed. New York: Wiley, (2002)

  41. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer staging manual, 6th ed. New York: Springer, 2002; pp 5–226.

    Google Scholar 

  42. Bertagnolli M, Miedema B, Redson M, et al. Sentinel node staging of resectable colon cancer, results of a multicenter study. Ann Surg 2004; 240:624–30

    PubMed  Google Scholar 

  43. Redson M, Compton CC, Miedema B, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol 2006; 24(6):878–83

    Article  Google Scholar 

  44. Saha S, Dan AG, Viehl CT, Zuber M, Wiese D. Sentinel lymph node mapping in colon and rectal cancer: its impact on staging, limitations, and pitfalls. Cancer Treat Res 2005; 127:105–22.

    Article  PubMed  Google Scholar 

  45. Turner RR, Nora DT, Trocha SD, Bilchik AJ. Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med 2003; 127:673–9

    PubMed  Google Scholar 

  46. Saha S, Seghal R, Patel M, et al. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 2006; 191:305–10

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Supported in part by grant CA090848 from the National Cancer Institute and by funding from the Rod Fasone Memorial Cancer Fund (Indianapolis, IN), the Henry L. Guenther Foundation (Los Angeles, CA), the William Randolph Hearst Foundation (San Francisco, CA) and the Davidow Charitable Fund (Los Angeles, CA), The Point Grey Charitable Trust, Gary Coull Trustee (Hong Kong, China), Mr. and Mrs. Sheldon E. Stunkel.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA, USA

    Douglas Iddings DO, Aziz Ahmad MD & Anton Bilchik MD, PhD

  2. John Wayne Cancer Institute at Saint John’s Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA, 90404, USA

    David Elashoff & Anton Bilchik MD, PhD

Authors
  1. Douglas Iddings DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aziz Ahmad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Elashoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anton Bilchik MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anton Bilchik MD, PhD.

Additional information

Oral presentation at the 2006 annual meeting of the Society of Surgical Oncology (SSO).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iddings, D., Ahmad, A., Elashoff, D. et al. The Prognostic Effect of Micrometastases in Previously Staged Lymph Node Negative (N0) Colorectal Carcinoma: A Meta-analysis. Ann Surg Oncol 13, 1386–1392 (2006). https://doi.org/10.1245/s10434-006-9120-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9120-y

Keywords

Search

Navigation